Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $130.3000 (5.75%) ($130.3000 - $130.3000) on Tue. Jan. 19, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.21% (three month average) | RSI | 74 | Latest Price | $130.3000(5.75%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 3.6% a day on average for past five trading days. | Weekly Trend | LGND advances 9.3% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(56%) IWO(54%) IWM(51%) IWC(50%) XBI(50%) | Factors Impacting LGND price | LGND will decline at least -1.605% in a week (0% probabilities). VIXM(-23%) UUP(-17%) VXX(-15%) UNG(-3%) TBT(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.605% (StdDev 3.21%) | Hourly BBV | 1.1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $119.44(9.09%) | 10 Day Moving Average | $112.79(15.52%) | 20 Day Moving Average | $107.53(21.18%) | To recent high | 0% | To recent low | 62.2% | Market Cap | $2.094b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |